IDEAS home Printed from https://ideas.repec.org/a/nat/nature/v627y2024i8002d10.1038_s41586-023-07009-0.html
   My bibliography  Save this article

Genetic determinants of micronucleus formation in vivo

Author

Listed:
  • D. J. Adams

    (Wellcome Sanger Institute)

  • B. Barlas

    (University of Cambridge
    University of Cambridge)

  • R. E. McIntyre

    (Wellcome Sanger Institute)

  • I. Salguero

    (University of Cambridge)

  • L. Weyden

    (Wellcome Sanger Institute)

  • A. Barros

    (Wellcome Sanger Institute
    University of Cambridge)

  • J. R. Vicente

    (University of Cambridge
    University of Cambridge)

  • N. Karimpour

    (University of Cambridge
    University of Cambridge)

  • A. Haider

    (University of Cambridge
    University of Cambridge)

  • M. Ranzani

    (Wellcome Sanger Institute)

  • G. Turner

    (Wellcome Sanger Institute)

  • N. A. Thompson

    (Wellcome Sanger Institute)

  • V. Harle

    (Wellcome Sanger Institute)

  • R. Olvera-León

    (Wellcome Sanger Institute)

  • C. D. Robles-Espinoza

    (Wellcome Sanger Institute
    Universidad Nacional Autónoma de México)

  • A. O. Speak

    (Wellcome Sanger Institute)

  • N. Geisler

    (Wellcome Sanger Institute
    University of Cambridge)

  • W. J. Weninger

    (Medical University of Vienna)

  • S. H. Geyer

    (Medical University of Vienna)

  • J. Hewinson

    (Wellcome Sanger Institute)

  • N. A. Karp

    (Wellcome Sanger Institute)

  • B. Fu

    (Wellcome Sanger Institute)

  • F. Yang

    (Wellcome Sanger Institute)

  • Z. Kozik

    (The Institute of Cancer Research)

  • J. Choudhary

    (The Institute of Cancer Research)

  • L. Yu

    (The Institute of Cancer Research)

  • M. S. Ruiten

    (The Netherlands Cancer Institute)

  • B. D. Rowland

    (The Netherlands Cancer Institute)

  • C. J. Lelliott

    (Wellcome Sanger Institute)

  • M. Castillo Velasco-Herrera

    (Wellcome Sanger Institute)

  • R. Verstraten

    (Wellcome Sanger Institute)

  • L. Bruckner

    (Experimental and Clinical Research Center (ECRC) of the MDC and Charité Berlin
    Max-Delbrück-Centrum für Molekulare Medizin)

  • A. G. Henssen

    (Experimental and Clinical Research Center (ECRC) of the MDC and Charité Berlin
    Max-Delbrück-Centrum für Molekulare Medizin
    Charité—Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin
    partner site Berlin, and German Cancer Research Center (DKFZ))

  • M. A. Rooimans

    (Amsterdam UMC, Vrije Universiteit Amsterdam
    Cancer Biology and Immunology)

  • J. Lange

    (Amsterdam UMC, Vrije Universiteit Amsterdam
    Cancer Biology and Immunology)

  • T. J. Mohun

    (MRC, National Institute for Medical Research)

  • M. J. Arends

    (Cancer Research UK Scotland Centre, Institute of Genetics & Cancer The University of Edinburgh)

  • K. A. Kentistou

    (Wellcome-MRC Institute of Metabolic Science, University of Cambridge School of Clinical Medicine)

  • P. A. Coelho

    (University of Cambridge)

  • Y. Zhao

    (University of Cambridge
    University of Cambridge)

  • H. Zecchini

    (Wellcome-MRC Institute of Metabolic Science, University of Cambridge School of Clinical Medicine)

  • J. R. B. Perry

    (Wellcome-MRC Institute of Metabolic Science, University of Cambridge School of Clinical Medicine
    Wellcome-MRC Institute of Metabolic Science, University of Cambridge School of Clinical Medicine)

  • S. P. Jackson

    (University of Cambridge
    Cancer Research UK Cambridge Institute)

  • G. Balmus

    (Wellcome Sanger Institute
    University of Cambridge
    University of Cambridge
    University of Cambridge)

Abstract

Genomic instability arising from defective responses to DNA damage1 or mitotic chromosomal imbalances2 can lead to the sequestration of DNA in aberrant extranuclear structures called micronuclei (MN). Although MN are a hallmark of ageing and diseases associated with genomic instability, the catalogue of genetic players that regulate the generation of MN remains to be determined. Here we analyse 997 mouse mutant lines, revealing 145 genes whose loss significantly increases (n = 71) or decreases (n = 74) MN formation, including many genes whose orthologues are linked to human disease. We found that mice null for Dscc1, which showed the most significant increase in MN, also displayed a range of phenotypes characteristic of patients with cohesinopathy disorders. After validating the DSCC1-associated MN instability phenotype in human cells, we used genome-wide CRISPR–Cas9 screening to define synthetic lethal and synthetic rescue interactors. We found that the loss of SIRT1 can rescue phenotypes associated with DSCC1 loss in a manner paralleling restoration of protein acetylation of SMC3. Our study reveals factors involved in maintaining genomic stability and shows how this information can be used to identify mechanisms that are relevant to human disease biology1.

Suggested Citation

  • D. J. Adams & B. Barlas & R. E. McIntyre & I. Salguero & L. Weyden & A. Barros & J. R. Vicente & N. Karimpour & A. Haider & M. Ranzani & G. Turner & N. A. Thompson & V. Harle & R. Olvera-León & C. D. , 2024. "Genetic determinants of micronucleus formation in vivo," Nature, Nature, vol. 627(8002), pages 130-136, March.
  • Handle: RePEc:nat:nature:v:627:y:2024:i:8002:d:10.1038_s41586-023-07009-0
    DOI: 10.1038/s41586-023-07009-0
    as

    Download full text from publisher

    File URL: https://www.nature.com/articles/s41586-023-07009-0
    File Function: Abstract
    Download Restriction: Access to the full text of the articles in this series is restricted.

    File URL: https://libkey.io/10.1038/s41586-023-07009-0?utm_source=ideas
    LibKey link: if access is restricted and if your library uses this service, LibKey will redirect you to where you can use your library subscription to access this item
    ---><---

    As the access to this document is restricted, you may want to search for a different version of it.

    More about this item

    Statistics

    Access and download statistics

    Corrections

    All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:nat:nature:v:627:y:2024:i:8002:d:10.1038_s41586-023-07009-0. See general information about how to correct material in RePEc.

    If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.

    We have no bibliographic references for this item. You can help adding them by using this form .

    If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.

    For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Sonal Shukla or Springer Nature Abstracting and Indexing (email available below). General contact details of provider: http://www.nature.com .

    Please note that corrections may take a couple of weeks to filter through the various RePEc services.

    IDEAS is a RePEc service. RePEc uses bibliographic data supplied by the respective publishers.